"Human Fetal Diploid Cells
Two different strains of human diploid cell cultures made from fetuses have been used extensively for vaccine production for decades. One was developed in the United States in 1961 (called WI-38) and the other in the United Kingdom in 1966 (called MRC-5).WI-38 came from lung cells from a female fetus of 3-months gestation and MRC-5 was developed from lung cells from a 14-week-old male fetus. Both fetuses were intentionally aborted, but neither was aborted for the purpose of obtaining diploid cells. (6-8). The fetal tissues that eventually became WI-38 and the MRC-5 cell cultures were removed from fetuses that were dead. The cellular biologists who made the cell cultures did not induce the abortions.
Human diploid cells are batches of human cells that are grown in a laboratory. Unlike cancer cells, they have the same number of chromosomes as normal human cells.
Certain diploid cell strains are valuable in vaccine manufacture because these cells can be used for a very long period of time in the laboratory and are a reliable means by which many viruses that infect humans can be successfully and easily grown. Vaccines prepared in human diploid cells have proven to be very safe over the past several decades.
These two cell strains have been growing under laboratory conditions for more than 35 years. The cells are merely the biological system in which the viruses are grown. These cell strains do not and cannot form a complete organism and do not constitute a potential human being. The cells reproduce themselves, so there is no need to abort additional fetuses to sustain the culture supply. Viruses are collected from the diploid cell cultures and then processed further to produce the vaccine itself.
The WI-38 and MRC-5 cell cultures have been used to prepare hundreds of millions of doses of vaccines, preventing millions of cases of rubella, hepatitis A, varicella and rabies. . In the United States, only one of these diseases can be prevented with an FDA-licensed vaccine not grown in human diploid cells. This is the RabAvert brand of rabies vaccine manufactured by Chiron Corporation. (9)
Some of the vaccines that are produced in human diploid cells might now be able to be prepared in alternative types of cell cultures. Some of these cell cultures were not available or were not considered suitable for use in vaccines when the original vaccines were developed. However, there is no guarantee that vaccines grown in these alternative cell lines would be as safe and effective as currently licensed vaccines and development is likely to be extremely costly. Thus, there is little incentive for vaccine manufacturers to develop and test new vaccines when an existing licensed vaccine is known to be both safe and effective.
I changed the order of the paragraphs, but other wise this came directly from National Network for Immunization Information.
Here are the known vaccines which contain HDC.
A) Live vaccines against rubella8 :
- the monovalent vaccines against rubella Meruvax®!! (Merck) (U.S.), Rudivax® (Sanofi Pasteur, Fr.), and Ervevax® (RA 27/3) (GlaxoSmithKline, Belgium);- the combined vaccine MR against rubella and measles, commercialized with the name of M-R-VAX® (Merck, US) and Rudi-Rouvax® (AVP, France);- the combined vaccine against rubella and mumps marketed under the name of Biavax®!! (Merck, U.S.),- the combined vaccine MMR (measles, mumps, rubella) against rubella, mumps and measles, marketed under the name of M-M-R® II (Merck, US), R.O.R.®, Trimovax® (Sanofi Pasteur, Fr.), and Priorix® (GlaxoSmithKline UK).
B) Other vaccines, also prepared using human cell lines from aborted foetuses:
- two vaccines against hepatitis A, one produced by Merck (VAQTA), the other one produced by GlaxoSmithKline (HAVRIX), both of them being prepared using MRC-5;- one vaccine against chicken pox, Varivax®, produced by Merck using WI-38 and MRC-5;- one vaccine against poliomyelitis, the inactivated polio virus vaccine Poliovax® (Aventis-Pasteur, Fr.) using MRC-5;- one vaccine against rabies, Imovax®, produced by Aventis Pasteur, harvested from infected human diploid cells, MRC-5 strain;- one vaccine against smallpox, AC AM 1000, prepared by Acambis using MRC-5, still on trial.
Here is the Vatican’s statement on such, basically stating that for those vaccines which do not have a morally acceptable alternative, one should be made, but since this is passive formal cooperation of this sin by the vaccine manufacturers, and not by you, the recipient, it is more okay (if that’s okay?) since the alternative to not vaccinating can be more harmful, especially since many people have been saved.
To summarize, it must be confirmed that:
-there is a grave responsibility to use alternative vaccines and to make a conscientious objection with regard to those which have moral problems;- as regards the vaccines without an alternative, the need to contest so that others may be prepared must be reaffirmed, as should be the lawfulness of using the former in the meantime insomuch as is necessary in order to avoid a serious risk not only for one’s own children but also, and perhaps more specifically, for the health conditions of the population as a whole - especially for pregnant women;- the lawfulness of the use of these vaccines should not be misinterpreted as a declaration of the lawfulness of their production, marketing and use, but is to be understood as being a passive material cooperation and, in its mildest and remotest sense, also active, morally justified as an extrema ratio due to the necessity to provide for the good of one’s children and of the people who come in contact with the children (pregnant women);- such cooperation occurs in a context of moral coercion of the conscience of parents, who are forced to choose to act against their conscience or otherwise, to put the health of their children and of the population as a whole at risk. This is an unjust alternative choice, which must be eliminated as soon as possible.
No comments:
Post a Comment